Position
Chief Executive Officer
Company
Shennon Biotechnologies
Description
Shennon Biotechnologies has appointed Cyril Konto, M.D., as its Chief Executive Officer. This appointment comes alongside the company's recent financing round of $12M and the unveiling of its precision immunotherapy pipeline.
Quick answer
Shennon Biotechnologies Appoints Cyril Konto as Chief Executive Officer (September 14, 2026). Shennon Biotechnologies is based in San Francisco, California, United States.
- What did Shennon Biotechnologies announce on September 14, 2026?
- Shennon Biotechnologies has appointed Cyril Konto, M.D., as its Chief Executive Officer. This appointment comes alongside the company's recent financing round of $12M and the unveiling of its precision immunotherapy pipeline.
- What does Shennon Biotechnologies do?
- ShennonBio has developed a proprietary platform that can profile millions of immune cells functionally at the single cell level at unprecedented throughput and accuracy, which resolves a key bottleneck in immunotherapy.
- Where is Shennon Biotechnologies based?
- Shennon Biotechnologies is based in San Francisco, California, United States.
- Which similar companies made leadership changes around the same time?
- Vyome Holdings (September 14, 2026), Mesothelioma UK (September 14, 2026), BLOC (Biopharma Leaders of Color) (September 14, 2026) and Q32 Bio (September 14, 2026) also announced leadership changes within 45 days of Shennon Biotechnologies.
Source: Fundz verified event record.
Other recent leadership changes in Biotechnology
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Vyome Appoints Jerry Leonard as Chief Financial Officer (September 14, 2026)
- Mesothelioma UK Appoints Hannah Moody as Chief Executive Officer (September 14, 2026)
- BLOC Appoints Jeff Raphael as Executive Director (September 14, 2026)
- Q32 Bio Appoints José Trevejo as Chief Medical Officer and Ellie Hershberger as Chief Development Officer (September 14, 2026)
- Slate Medicines Appoints Kenneth Koblan as Chief Scientific Officer (September 14, 2026)
- Outcomes4Me Appoints Jim Longley as Chief Revenue Officer (September 14, 2026)
Who to call at Shennon Biotechnologies, and when
A new leader at Shennon Biotechnologies brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Shennon Biotechnologies raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Shennon Biotechnologies, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Shennon Biotechnologies. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Shennon Biotechnologies changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Shennon Biotechnologies changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.